Observational studyThe oncologist2026

Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selection.

Letizia Procaccio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.